Prostatic Carcinoma
Prostatic carcinoma, commonly known as prostate cancer, remains a leading cause of cancer-related morbidity and mortality among men worldwide. Early detection, accurate staging, and evolving…
Non-Metastatic Castration-Resistant Prostate Cancer
Non-metastatic castration-resistant prostate cancer (nmCRPC) is a clinically distinct phase of prostate cancer characterized by biochemical progression despite androgen deprivation therapy (ADT), in the absence…
Metastatic Prostate Carcinoma
Metastatic prostate carcinoma is an advanced stage of prostate cancer, in which malignant cells spread beyond the prostate gland to distant organs, most commonly bones,…
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Metastatic castration-sensitive prostate cancer (mCSPC) is an advanced stage of prostate cancer where cancer cells have spread beyond the prostate gland to other parts of…
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Metastatic Castration-Resistant Prostate Cancer (mCRPC) is an advanced form of prostate cancer that continues to progress despite androgen deprivation therapy (ADT). In this stage, cancer…
Loss of Bone Mineral Density (BMD)
Androgen deprivation therapy (ADT) is a cornerstone treatment for advanced prostate cancer, effectively reducing testosterone levels to slow cancer progression. However, this therapy is associated…